Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Change in Taxes: 2020-2024

Historic Change in Taxes for Silence Therapeutics (SLN) over the last 4 years, with Sep 2024 value amounting to $4.1 million.

  • Silence Therapeutics' Change in Taxes rose 33.85% to $4.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $11.4 million, marking a year-over-year increase of 6.68%. This contributed to the annual value of $4.5 million for FY2020, which is 6.87% up from last year.
  • Latest data reveals that Silence Therapeutics reported Change in Taxes of $4.1 million as of Q3 2024, which was up 72.35% from $2.4 million recorded in Q2 2024.
  • Over the past 5 years, Silence Therapeutics' Change in Taxes peaked at $2.0 billion during Q1 2021, and registered a low of -$3.6 billion during Q4 2020.
  • Its 3-year average for Change in Taxes is $2.6 million, with a median of $2.5 million in 2022.
  • Its Change in Taxes has fluctuated over the past 5 years, first tumbled by 99.87% in 2022, then spiked by 33.85% in 2024.
  • Quarterly analysis of 5 years shows Silence Therapeutics' Change in Taxes stood at -$3.6 billion in 2020, then plummeted by 99.51% to $2.9 million in 2021, then dropped by 10.48% to $2.6 million in 2022, then grew by 16.57% to $3.1 million in 2023, then spiked by 33.85% to $4.1 million in 2024.
  • Its last three reported values are $4.1 million in Q3 2024, $2.4 million for Q2 2024, and $1.9 million during Q1 2024.